BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Phase I Study
Phase of Trial: Phase I
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Alpelisib (Primary) ; Capecitabine
- Indications Rectal cancer
- Focus Adverse reactions
- 26 Feb 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 26 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2019.
- 03 Jun 2016 Status changed from not yet recruiting to recruiting.